OSC Co-culture for Rescue IVM of Human GV Oocytes
- Sponsor
- Hung Vuong Hospital
- Study ID
- NCT07559357
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Infertility
- Oocyte Maturation
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Conventional rescue in vitro maturation — OTHERStandard rescue in vitro maturation of denuded germinal vesicle oocytes in CSCMC culture medium for 24 hours under routine IVF laboratory conditions.
- Rescue in vitro maturation with iPSC-derived ovarian support cell co-culture — OTHERRescue in vitro maturation of denuded germinal vesicle oocytes in CSCMC culture medium for 24 hours with co-culture using iPSC-derived ovarian support cells supplied by Dioseve Inc. and prepared according to the laboratory SOP.
Study Details
This single-center randomized sibling-oocyte controlled trial evaluates whether co-culture with induced pluripotent stem cell (iPSC)-derived ovarian support cells (OSCs) improves rescue in vitro maturation (r-IVM) outcomes of surplus germinal vesicle (GV) oocytes collected during routine IVF treatment. Eligible GV oocytes from each enrolled participant are allocated within participant in a 1:1 ratio to either conventional r-IVM or r-IVM with OSC co-culture. The primary outcome is the metaphase II (MII) maturation rate after 24 hours of culture. Secondary outcomes include fertilization rate, day 3 embryo formation, good-quality day 3 embryo rate, blastocyst formation, and good-quality blastocyst rate. All embryos generated in the study are for research purposes only and will not be used for clinical embryo transfer.
Key Dates
- First listed
- Apr 30, 2026
- Start date
- Jun 30, 2026
- Status verified
- Apr 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 102 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Conventional r-IVMEligible GV oocytes are cultured for 24 hours in standard CSCMC medium under routine rescue in vitro maturation conditions without ovarian support cell co-culture.
- Experimental: r-IVM with iPSC-Derived OSC Co-cultureEligible GV oocytes are cultured for 24 hours in CSCMC medium with co-culture using iPSC-derived ovarian support cells prepared according to laboratory SOPs.
Primary Outcome Measure
MII maturation rate after 24 hours of culture [ Time Frame: 24 hours after initiation of culture ]
Central Contacts
- Huy Phuong Tran, PhD+84 896 416 098
Related Studies
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California
- Discarded Materials StudyRecruiting · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Study of Gene Associations and InfertilityEnrolling By Invitation · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Inherited Reproductive DisordersRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Bethesda, Maryland